Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

95 structures for Q8N884

Entry ID Method Resolution Chain Position Source
4KM5 X-ray 250 A A 157-522 PDB
4LEV X-ray 195 A A/B 157-522 PDB
4LEW X-ray 204 A A/B 157-522 PDB
4MKP X-ray 195 A A 161-522 PDB
4O67 X-ray 244 A A/B 161-522 PDB
4O68 X-ray 244 A A 147-522 PDB
4O69 X-ray 225 A A 161-522 PDB
5V8O X-ray 310 A A/B 161-522 PDB
5VDO X-ray 322 A A/B 161-522 PDB
5VDP X-ray 230 A A/B 161-522 PDB
5VDQ X-ray 325 A A/B 161-522 PDB
5VDR X-ray 304 A A/B 161-522 PDB
5VDS X-ray 277 A A/B 161-522 PDB
5VDT X-ray 258 A A/B 161-522 PDB
5VDU X-ray 273 A A/B 161-522 PDB
5VDV X-ray 300 A A/B 161-522 PDB
5VDW X-ray 271 A A/B 161-522 PDB
6CT9 X-ray 226 A A 157-522 PDB
6CTA X-ray 278 A A 157-522 PDB
6EDB X-ray 321 A A/B 157-522 PDB
6EDC X-ray 271 A A 157-522 PDB
6LRC X-ray 183 A A/B 157-522 PDB
6LRE X-ray 265 A A/B 157-522 PDB
6LRI X-ray 250 A A/B 157-522 PDB
6LRJ X-ray 300 A A/B 157-522 PDB
6LRK X-ray 225 A A/B 157-522 PDB
6LRL X-ray 265 A A/B 157-522 PDB
6MJU X-ray 245 A A 152-522 PDB
6MJW X-ray 240 A A 152-522 PDB
6MJX X-ray 260 A A 152-522 PDB
6NAO X-ray 323 A A/B 161-522 PDB
6NFG X-ray 276 A A/B 161-522 PDB
6NFO X-ray 293 A A/B 161-522 PDB
6O47 X-ray 220 A A 152-522 PDB
6Y5D EM 410 A K/L 161-522 PDB
6Y5E EM 315 A K 161-522 PDB
7C0M EM 390 A K/k 151-522 PDB
7CCQ EM 380 A K 157-522 PDB
7CCR EM 490 A K/V 157-522 PDB
7FTF X-ray 151 A A 161-522 PDB
7FTG X-ray 173 A A/B 161-522 PDB
7FTH X-ray 255 A A 161-522 PDB
7FTI X-ray 200 A A 161-522 PDB
7FTJ X-ray 146 A A 161-522 PDB
7FTK X-ray 212 A A/B 161-522 PDB
7FTL X-ray 220 A A 161-522 PDB
7FTM X-ray 170 A A 161-522 PDB
7FTN X-ray 200 A A 161-522 PDB
7FTO X-ray 240 A A 161-522 PDB
7FTP X-ray 248 A A 161-522 PDB
7FTQ X-ray 208 A A 161-522 PDB
7FTR X-ray 164 A A 161-522 PDB
7FTS X-ray 221 A A 161-522 PDB
7FTT X-ray 223 A A/B 161-522 PDB
7FTU X-ray 165 A A 161-522 PDB
7FTV X-ray 188 A A 161-522 PDB
7FTW X-ray 221 A A 161-522 PDB
7FTX X-ray 283 A A 161-522 PDB
7FTY X-ray 230 A A 161-522 PDB
7FTZ X-ray 250 A A/B 161-522 PDB
7FU0 X-ray 197 A A 161-522 PDB
7FU1 X-ray 207 A A 161-522 PDB
7FU2 X-ray 230 A A 161-522 PDB
7FU3 X-ray 182 A A 161-522 PDB
7FU4 X-ray 193 A A 161-522 PDB
7FU5 X-ray 218 A A/B 161-522 PDB
7FU6 X-ray 237 A A 161-522 PDB
7FU7 X-ray 224 A A 161-522 PDB
7FU8 X-ray 172 A A 161-522 PDB
7FU9 X-ray 167 A A 161-522 PDB
7FUA X-ray 144 A A 161-522 PDB
7FUB X-ray 198 A A 161-522 PDB
7FUC X-ray 252 A A 161-522 PDB
7FUD X-ray 203 A A/B 161-522 PDB
7FUE X-ray 217 A A 161-522 PDB
7FUF X-ray 192 A A 161-522 PDB
7FUG X-ray 211 A A/B 161-522 PDB
7FUH X-ray 194 A A 161-522 PDB
7FUI X-ray 174 A A 161-522 PDB
7FUJ X-ray 179 A A 161-522 PDB
7FUK X-ray 161 A A 161-522 PDB
7FUL X-ray 230 A A 161-522 PDB
7FUM X-ray 206 A A 161-522 PDB
7FUN X-ray 207 A A 161-522 PDB
7FUO X-ray 181 A A 161-522 PDB
7FUP X-ray 241 A A 161-522 PDB
7FUQ X-ray 176 A A 161-522 PDB
7FUR X-ray 170 A A 161-522 PDB
8IME X-ray 263 A A/B 157-522 PDB
8IMF X-ray 240 A A/B 157-522 PDB
8IMG X-ray 180 A A/B 157-522 PDB
8OKX EM 351 A A 156-522 PDB
8OL1 EM 350 A K 161-522 PDB
8WR8 X-ray 310 A A/B 161-522 PDB
AF-Q8N884-F1 Predicted AlphaFoldDB

453 variants for Q8N884

Variant ID(s) Position Change Description Diseaes Association Provenance
CA364711663
rs774733961
3 P>L No ClinGen
ExAC
TOPMed
gnomAD
CA3889179
rs774733961
3 P>R No ClinGen
ExAC
TOPMed
gnomAD
CA364711665
rs1406989312
3 P>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA3889178
rs770727137
5 H>Y No ClinGen
ExAC
gnomAD
rs1582660495
CA364711632
8 A>P No ClinGen
Ensembl
CA364711621
rs1484111485
9 M>I No ClinGen
gnomAD
CA364711623
rs1167718559
9 M>T No ClinGen
TOPMed
CA3889177
rs34605178
9 M>V No ClinGen
ExAC
TOPMed
gnomAD
rs1255208821
CA364711613
10 Q>L No ClinGen
gnomAD
CA364711601
rs1306771526
12 A>D No ClinGen
gnomAD
CA3889176
rs777423092
12 A>S No ClinGen
ExAC
gnomAD
rs926391717
CA140941514
13 S>Y No ClinGen
Ensembl
rs1405966339
CA364711593
14 E>K No ClinGen
TOPMed
CA3889172
rs754846031
15 A>P No ClinGen
ExAC
gnomAD
CA364711585
rs754846031
15 A>T No ClinGen
ExAC
gnomAD
rs751343807
CA3889171
16 G>* No ClinGen
ExAC
gnomAD
CA364711578
rs1451941695
16 G>E Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs147035222
RCV000953228
CA3889170
17 A>G No ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs1344337430
CA364711575
17 A>T No ClinGen
gnomAD
rs753993852
CA3889168
21 K>R No ClinGen
ExAC
gnomAD
rs1307042642
CA364711544
22 A>T No ClinGen
TOPMed
gnomAD
CA140941488
rs966509155
22 A>V No ClinGen
TOPMed
rs1444650325
CA364711536
23 S>F No ClinGen
gnomAD
CA3889166
rs760649119
24 A>S No ClinGen
ExAC
TOPMed
gnomAD
CA364711530
rs1314022859
24 A>V No ClinGen
gnomAD
CA3889164
rs767939944
25 R>L No ClinGen
ExAC
TOPMed
gnomAD
rs767939944
CA364711527
25 R>P No ClinGen
ExAC
TOPMed
gnomAD
CA364711528
rs767939944
25 R>Q No ClinGen
ExAC
TOPMed
gnomAD
CA3889165
rs372417314
25 R>W No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs774867546
CA364711512
28 R>G No ClinGen
ExAC
TOPMed
gnomAD
rs774867546
CA3889162
28 R>W No ClinGen
ExAC
TOPMed
gnomAD
CA364711503
rs1245895147
29 G>D No ClinGen
gnomAD
CA364711504
rs1290150050
29 G>S No ClinGen
gnomAD
rs1314973747
CA364711499
30 A>P No ClinGen
gnomAD
CA364711495
rs1380722770
30 A>V No ClinGen
gnomAD
CA364711490
rs1361576360
31 P>Q No ClinGen
gnomAD
CA3889160
rs762757889
32 M>L No ClinGen
ExAC
gnomAD
CA3889159
rs772990516
33 D>V No ClinGen
ExAC
CA3889158
rs769481836
34 P>S No ClinGen
ExAC
gnomAD
rs1192658709
CA364711467
35 T>A No ClinGen
TOPMed
rs9352000
CA3889156
VAR_050811
35 T>N No ClinGen
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA3889157
rs9352000
35 T>S No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA364711462
rs1369636757
36 E>* No ClinGen
TOPMed
gnomAD
CA364711457
rs1561933242
36 E>D No ClinGen
Ensembl
rs1369636757
CA364711464
36 E>K No ClinGen
TOPMed
gnomAD
CA364711453
rs746906830
37 S>C No ClinGen
ExAC
TOPMed
gnomAD
CA3889154
rs746906830
37 S>F No ClinGen
ExAC
TOPMed
gnomAD
rs779830325
CA364711451
38 P>A Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs758174938
CA3889152
38 P>L No ClinGen
ExAC
gnomAD
rs779830325
CA3889153
38 P>T No ClinGen
ExAC
gnomAD
CA3889150
rs777938732
39 A>P No ClinGen
ExAC
TOPMed
gnomAD
rs756318362
CA3889149
40 A>V No ClinGen
ExAC
TOPMed
gnomAD
rs1357735901
CA364711433
41 P>L No ClinGen
gnomAD
rs1357735901
CA364711434
41 P>R No ClinGen
gnomAD
CA3889147
rs767573211
41 P>S No ClinGen
ExAC
TOPMed
CA140941362
rs901219481
42 E>* No ClinGen
TOPMed
gnomAD
CA364711432
rs901219481
42 E>K No ClinGen
TOPMed
gnomAD
CA364711431
rs901219481
42 E>Q No ClinGen
TOPMed
gnomAD
rs752104616
CA3889145
43 A>D No ClinGen
ExAC
TOPMed
gnomAD
CA3889146
rs755440893
43 A>T No ClinGen
ExAC
TOPMed
gnomAD
rs752104616
CA364711422
43 A>V No ClinGen
ExAC
TOPMed
gnomAD
CA364711400
rs1561933207
47 K>R No ClinGen
Ensembl
CA3889143
rs35629782
48 A>E No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA3889144
rs766912294
48 A>S No ClinGen
ExAC
TOPMed
gnomAD
rs1448918635
CA364711389
49 G>E No ClinGen
TOPMed
rs761478616
CA3889140
CA3889141
50 K>N No ClinGen
ExAC
TOPMed
gnomAD
CA140941291
rs1048612855
53 P>A No ClinGen
TOPMed
gnomAD
rs1048612855
CA140941289
53 P>S No ClinGen
TOPMed
gnomAD
CA3889139
rs769976348
54 A>S No ClinGen
ExAC
TOPMed
gnomAD
rs769976348
CA364711362
54 A>T No ClinGen
ExAC
TOPMed
gnomAD
CA3889138
rs768147921
55 R>G No ClinGen
ExAC
gnomAD
CA364711354
rs1172325497
55 R>M No ClinGen
gnomAD
CA364711352
rs34985291
55 R>S No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA140941266
rs539927816
56 K>N No ClinGen
1000Genomes
gnomAD
rs1452688603
CA364711329
59 S>Y No ClinGen
gnomAD
rs1194601988
CA364711326
60 R>W No ClinGen
TOPMed
gnomAD
CA140941257
rs943315453
62 K>* No ClinGen
TOPMed
gnomAD
rs572861541
CA3889135
63 K>Q No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1200706493
CA364711293
64 S>R No ClinGen
gnomAD
CA364711289
rs1582660295
65 A>S No ClinGen
Ensembl
CA140941247
rs370645038
66 P>R No ClinGen
gnomAD
CA364711283
rs1282360336
66 P>S No ClinGen
gnomAD
rs1561933159
CA364711268
68 T>S No ClinGen
Ensembl
rs1390782804
CA364711261
69 Q>L No ClinGen
gnomAD
rs913614476
CA140941219
70 E>G No ClinGen
TOPMed
gnomAD
CA364711247
rs1400336397
71 R>M No ClinGen
gnomAD
TCGA novel 72 P>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA364711234
rs1467874488
73 P>R No ClinGen
gnomAD
rs1332853713
CA364711236
73 P>S No ClinGen
gnomAD
rs375723811
CA140941175
74 V>F No ClinGen
TOPMed
gnomAD
rs375723811
CA140941177
74 V>I No ClinGen
TOPMed
gnomAD
rs1478528698
CA364711228
75 R>C No ClinGen
gnomAD
CA364711220
rs1291310244
76 A>G No ClinGen
TOPMed
rs987846250
CA364711222
76 A>P No ClinGen
TOPMed
gnomAD
rs987846250
CA140941169
76 A>S No ClinGen
TOPMed
gnomAD
rs987846250
CA140941173
76 A>T No ClinGen
TOPMed
gnomAD
rs1419025132
CA364711217
77 T>A No ClinGen
TOPMed
gnomAD
rs980310855
CA364711215
77 T>N No ClinGen
TOPMed
rs1419025132
CA364711218
77 T>P No ClinGen
TOPMed
gnomAD
rs980310855
CA140941150
77 T>S No ClinGen
TOPMed
CA364711199
rs1460144649
80 R>C No ClinGen
TOPMed
gnomAD
CA140941149
rs866696488
80 R>H No ClinGen
TOPMed
gnomAD
CA364711197
rs866696488
80 R>L No ClinGen
TOPMed
gnomAD
rs1460144649
CA364711201
80 R>S No ClinGen
TOPMed
gnomAD
CA364711196
rs200213844
81 A>P No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA3889131
rs200213844
81 A>T No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
TCGA novel 81 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1346816677
CA364711189
82 K>E No ClinGen
TOPMed
gnomAD
rs748331365
CA3889130
82 K>T No ClinGen
ExAC
TOPMed
gnomAD
CA364711173
rs1377613168
84 A>D No ClinGen
TOPMed
gnomAD
CA364711171
rs1377613168
84 A>V No ClinGen
TOPMed
gnomAD
CA140941132
rs953388880
86 Q>* No ClinGen
gnomAD
CA3889127
rs752163963
86 Q>L No ClinGen
ExAC
TOPMed
gnomAD
CA364711154
rs1415849924
87 R>P No ClinGen
gnomAD
rs1024891888
CA140941124
88 A>S No ClinGen
TOPMed
gnomAD
CA364711152
rs1024891888
88 A>T No ClinGen
TOPMed
gnomAD
RCV000709898
rs749545076
89 Q>missing No ClinVar
dbSNP
CA364711142
rs1304962186
89 Q>R No ClinGen
TOPMed
CA3889124
rs758938193
93 P>S No ClinGen
ExAC
gnomAD
rs758938193
CA364711117
93 P>T No ClinGen
ExAC
gnomAD
rs1026365134
CA140941119
94 S>F No ClinGen
TOPMed
CA364711107
rs1407535069
95 D>N No ClinGen
Ensembl
rs750841042
CA3889123
97 T>I No ClinGen
ExAC
TOPMed
gnomAD
CA3889122
rs141133909
101 G>R No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA364711064
rs1259366551
101 G>V No ClinGen
gnomAD
CA140941098
rs943276786
102 A>T No ClinGen
TOPMed
gnomAD
CA364711055
rs776344260
103 E>A No ClinGen
ExAC
gnomAD
CA3889120
rs776344260
103 E>G No ClinGen
ExAC
gnomAD
CA364711051
rs1358053788
104 G>R No ClinGen
gnomAD
CA140941048
rs1015622683
106 E>K No ClinGen
TOPMed
rs200136243
CA3889118
107 P>A No ClinGen
1000Genomes
ExAC
gnomAD
CA364711028
rs769416693
108 P>A No ClinGen
ExAC
TOPMed
gnomAD
CA3889117
rs769416693
108 P>T No ClinGen
ExAC
TOPMed
gnomAD
CA3889116
rs774941526
109 A>E No ClinGen
ExAC
TOPMed
gnomAD
rs1423321373
CA364711011
111 R>W No ClinGen
gnomAD
rs866098353
CA140941036
112 E>Q No ClinGen
Ensembl
rs1188740658
CA364711003
112 E>V No ClinGen
TOPMed
rs1163950892
CA364710995
113 P>L No ClinGen
gnomAD
rs1447658649
CA364710986
115 L>F No ClinGen
TOPMed
rs1582660138
CA364710982
116 S>A No ClinGen
Ensembl
rs772019128
CA3889115
116 S>F No ClinGen
ExAC
CA3889114
rs745744660
117 R>G No ClinGen
ExAC
gnomAD
CA3889113
rs774017782
117 R>T No ClinGen
ExAC
gnomAD
CA364710969
rs1220094691
118 A>D No ClinGen
TOPMed
gnomAD
rs1265107098
CA364710972
118 A>T No ClinGen
gnomAD
CA364710963
rs1225685356
119 G>A No ClinGen
TOPMed
rs545433028
CA364710966
119 G>R No ClinGen
TOPMed
gnomAD
rs545433028
CA140941006
119 G>S No ClinGen
TOPMed
gnomAD
rs1225685356
CA364710962
119 G>V No ClinGen
TOPMed
CA364710950
rs1289928785
121 C>Y No ClinGen
gnomAD
COSM4161347
rs1337026332
CA364710945
122 R>C thyroid [Cosmic] No ClinGen
cosmic curated
gnomAD
rs770753111
CA3889112
122 R>L No ClinGen
ExAC
TOPMed
gnomAD
rs748373505
CA3889111
123 Q>H No ClinGen
ExAC
gnomAD
TCGA novel 123 Q>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs781457078
CA3889110
124 R>K No ClinGen
ExAC
gnomAD
rs755056462
CA3889109
125 G>D No ClinGen
ExAC
TOPMed
gnomAD
rs755056462
CA364710925
125 G>V No ClinGen
ExAC
TOPMed
gnomAD
rs1349878419
CA364710920
126 A>E No ClinGen
gnomAD
rs1403605966
CA364710924
126 A>T No ClinGen
TOPMed
gnomAD
CA364710907
rs1324272884
128 C>F No ClinGen
gnomAD
CA3889108
rs552671009
129 S>F No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1407101416
CA364710902
129 S>P No ClinGen
gnomAD
CA364710903
rs1407101416
129 S>T No ClinGen
gnomAD
rs1414049930
CA364710896
130 T>K No ClinGen
TOPMed
CA3889107
rs527795978
132 P>A No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
TCGA novel 133 R>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA140940938
rs1003713332
133 R>S No ClinGen
Ensembl
CA364710878
rs1168016799
133 R>T No ClinGen
TOPMed
CA364710869
rs1478282750
134 P>L No ClinGen
gnomAD
CA3889104
rs1554146180
135 P>A Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
CA364710866
rs1403918612
135 P>Q No ClinGen
TOPMed
rs1477651842
CA364710863
136 P>A No ClinGen
gnomAD
rs757628777
CA3889102
137 G>E No ClinGen
ExAC
TOPMed
gnomAD
rs1247278348
CA364710855
137 G>R No ClinGen
gnomAD
rs757628777
CA3889101
137 G>V No ClinGen
ExAC
TOPMed
gnomAD
rs753472477
CA3889100
138 P>S No ClinGen
ExAC
gnomAD
rs763836802
CA3889099
139 W>G No ClinGen
ExAC
gnomAD
CA364710847
rs763836802
139 W>R No ClinGen
ExAC
gnomAD
CA364710834
rs1319608405
140 D>E No ClinGen
TOPMed
gnomAD
rs760271451
CA3889098
142 P>R No ClinGen
ExAC
gnomAD
rs1319229471
CA364710817
143 S>N No ClinGen
TOPMed
rs926274545
CA140940903
144 P>L No ClinGen
TOPMed
CA140940904
rs113374767
144 P>S No ClinGen
gnomAD
CA364710806
rs1330820242
145 G>D No ClinGen
TOPMed
gnomAD
CA364710809
rs373045600
145 G>R Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA3889095
rs373045600
145 G>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA3889093
rs770677150
146 L>Q No ClinGen
ExAC
gnomAD
rs770677150
CA3889094
146 L>R No ClinGen
ExAC
gnomAD
CA3889090
rs747174108
147 P>L No ClinGen
ExAC
TOPMed
gnomAD
CA3889089
rs747174108
147 P>R No ClinGen
ExAC
TOPMed
gnomAD
rs772844829
CA3889091
147 P>S No ClinGen
ExAC
gnomAD
TCGA novel 150 A>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs772276292
CA3889087
151 P>A No ClinGen
ExAC
TOPMed
gnomAD
CA3889085
rs779442760
152 I>T No ClinGen
ExAC
TOPMed
gnomAD
CA364710769
rs1561932931
153 L>F No ClinGen
Ensembl
rs754251787
CA3889083
155 R>Q No ClinGen
ExAC
TOPMed
gnomAD
CA364710756
rs1451835720
155 R>W Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs755764815
CA3889081
156 R>K No ClinGen
ExAC
gnomAD
rs752337338
CA3889080
156 R>S No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 157 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs767069356
CA3889079
158 A>V No ClinGen
ExAC
TOPMed
gnomAD
rs1371855931
CA364710735
159 A>T No ClinGen
gnomAD
CA140940834
rs1052171026
160 P>S No ClinGen
Ensembl
rs751494908
CA3889077
161 G>E No ClinGen
ExAC
gnomAD
CA364710719
rs1378402145
162 A>T No ClinGen
gnomAD
CA364710709
rs1370319039
163 S>W No ClinGen
TOPMed
rs754837044
CA140940827
165 L>P No ClinGen
Ensembl
CA3889076
rs370001875
166 R>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA364710693
rs556099079
166 R>W No ClinGen
TOPMed
CA364710689
rs141016543
167 A>E No ClinGen
ExAC
TOPMed
gnomAD
CA3889074
rs150220319
167 A>P No ClinGen
ExAC
TOPMed
gnomAD
CA3889075
rs150220319
167 A>T No ClinGen
ExAC
TOPMed
gnomAD
CA3889073
rs141016543
167 A>V No ClinGen
ExAC
TOPMed
gnomAD
CA364710677
rs1379678806
169 L>S No ClinGen
TOPMed
gnomAD
CA364710679
rs1379678806
169 L>W No ClinGen
TOPMed
gnomAD
CA3889072
rs761045584
171 K>E No ClinGen
ExAC
gnomAD
rs775843385
CA3889071
171 K>N No ClinGen
ExAC
gnomAD
CA3889069
rs745990535
174 L>F No ClinGen
ExAC
gnomAD
CA364710641
rs1478946136
174 L>P No ClinGen
TOPMed
CA3889068
rs774244760
177 D>G No ClinGen
ExAC
gnomAD
rs1191871186
CA364710608
179 I>S No ClinGen
TOPMed
rs985758497
CA140940775
179 I>V No ClinGen
Ensembl
CA3889066
rs373171892
181 T>A No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1582659898
CA364710562
186 V>G No ClinGen
Ensembl
rs1160737827
CA364710565
186 V>L No ClinGen
TOPMed
rs778174215
CA364710553
188 G>R No ClinGen
ExAC
gnomAD
CA3889064
rs369665603
188 G>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs778174215
CA3889065
188 G>W No ClinGen
ExAC
gnomAD
rs1582659888
CA364710544
189 V>G No ClinGen
Ensembl
CA364710531
rs1561932857
191 D>E No ClinGen
Ensembl
CA3889063
rs747844982
192 H>P No ClinGen
ExAC
gnomAD
rs1304355753
CA364710500
196 R>S No ClinGen
gnomAD
CA3889060
rs751105985
197 L>P No ClinGen
ExAC
gnomAD
rs372917212
CA3889058
198 K>R No ClinGen
ESP
ExAC
gnomAD
rs750324744
CA364710487
199 C>G No ClinGen
ExAC
gnomAD
rs750324744
CA3889057
199 C>R No ClinGen
ExAC
gnomAD
CA3889056
rs765184085
199 C>W No ClinGen
ExAC
TOPMed
gnomAD
rs1582659862
CA364710481
200 D>N No ClinGen
Ensembl
CA3889055
rs761679403
201 S>C No ClinGen
ExAC
TOPMed
gnomAD
CA140940684
rs761679403
201 S>F No ClinGen
ExAC
TOPMed
gnomAD
CA140940686
rs761679403
201 S>Y No ClinGen
ExAC
TOPMed
gnomAD
rs1415579925
CA364710469
202 A>S No ClinGen
gnomAD
rs1311066436
CA364710463
203 F>V No ClinGen
TOPMed
rs1353936037
CA364710457
204 R>G No ClinGen
TOPMed
rs776525430
CA3889054
204 R>S No ClinGen
ExAC
gnomAD
CA140940652
rs952772345
206 V>A No ClinGen
TOPMed
CA3889052
rs759618920
206 V>I No ClinGen
ExAC
gnomAD
CA3889050
rs369422354
CA364710411
212 G>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1453270785
CA364710404
213 S>R No ClinGen
TOPMed
CA364710394
rs1345101857
214 Y>C No ClinGen
gnomAD
CA140940618
rs936422794
215 Y>H No ClinGen
TOPMed
CA3889047
rs773683850
217 H>Q No ClinGen
ExAC
TOPMed
gnomAD
CA364710364
rs1298634797
218 V>A No ClinGen
gnomAD
rs375046828
CA3889046
218 V>L No ClinGen
ESP
ExAC
gnomAD
rs926410228
CA140940607
219 K>N No ClinGen
TOPMed
gnomAD
CA3889025
rs549985083
222 A>V No ClinGen
1000Genomes
ExAC
gnomAD
rs1033054939
CA140934462
223 P>A No ClinGen
Ensembl
CA364709495
rs1325265402
225 E>V No ClinGen
TOPMed
CA364709466
rs1424582665
227 D>V No ClinGen
Ensembl
CA364709468
rs1451822934
227 D>Y No ClinGen
TOPMed
gnomAD
rs1371821155
CA364709432
229 M>I No ClinGen
gnomAD
CA364709416
rs1200759497
230 F>C No ClinGen
TOPMed
gnomAD
rs1342559470
CA364709388
232 L>Q No ClinGen
TOPMed
gnomAD
TCGA novel 236 R>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs145259959
CA3889022
239 L>P No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA3889021
rs778507101
241 E>* No ClinGen
ExAC
TOPMed
gnomAD
rs757263892
CA3889020
241 E>D No ClinGen
ExAC
gnomAD
rs753822606
CA140934373
244 N>K No ClinGen
ExAC
TOPMed
gnomAD
rs369172604
CA3889018
246 R>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA3889017
rs755839580
246 R>H No ClinGen
ExAC
TOPMed
gnomAD
rs751844640
CA3889016
247 A>E No ClinGen
ExAC
gnomAD
CA3889015
rs766538455
248 Y>H No ClinGen
ExAC
gnomAD
rs763188406
CA3889014
249 Y>C No ClinGen
ExAC
gnomAD
rs750518997
CA3889013
250 F>S No ClinGen
ExAC
gnomAD
TCGA novel 256 N>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3889012
rs186630766
257 P>L No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA364709050
rs1258767367
257 P>T No ClinGen
gnomAD
rs610913
CA3889007
VAR_033677
261 P>H No ClinGen
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs610913
CA3889008
261 P>L No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1440957546
CA364708988
261 P>T No ClinGen
gnomAD
rs771633800
CA3889005
264 Q>R No ClinGen
ExAC
gnomAD
rs1158421245
CA364708892
267 E>D No ClinGen
TOPMed
rs371707799
CA3889004
267 E>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs770551313
CA3889002
268 G>D No ClinGen
ExAC
gnomAD
rs778631758
CA3889003
268 G>S No ClinGen
ExAC
gnomAD
CA364708871
rs1340916064
269 E>G No ClinGen
gnomAD
rs1333911244
CA364708828
272 S>P No ClinGen
gnomAD
rs1403006912
CA364708791
275 K>* No ClinGen
TOPMed
rs1377654649
CA364708731
279 K>R No ClinGen
TOPMed
gnomAD
rs780985384
CA3888997
280 F>L No ClinGen
ExAC
gnomAD
CA3888996
rs758627851
281 R>G No ClinGen
ExAC
TOPMed
gnomAD
rs1347065196
CA364708703
281 R>K No ClinGen
TOPMed
rs750643153
CA3888994
284 I>L No ClinGen
ExAC
gnomAD
rs765362734
CA3888993
285 K>N No ClinGen
ExAC
TOPMed
gnomAD
rs1278779578
CA364708652
285 K>Q No ClinGen
TOPMed
TCGA novel 287 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs955664376
CA140934223
289 N>D No ClinGen
TOPMed
CA3888990
rs764541437
290 D>G No ClinGen
ExAC
TOPMed
gnomAD
rs754409437
CA3888991
290 D>N No ClinGen
ExAC
gnomAD
rs1220431139
CA364708533
293 D>H No ClinGen
TOPMed
CA3888965
rs774812567
294 T>A No ClinGen
ExAC
TOPMed
gnomAD
CA3888964
rs183690204
294 T>I No ClinGen
1000Genomes
ExAC
gnomAD
CA3888963
rs183690204
294 T>R No ClinGen
1000Genomes
ExAC
gnomAD
CA364707854
rs1256552652
295 D>N No ClinGen
TOPMed
gnomAD
CA3888962
rs772605312
297 I>T No ClinGen
ExAC
gnomAD
TCGA novel 298 M>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1365945469
CA364707826
299 K>E No ClinGen
TOPMed
VAR_085524 303 G>E found in patients with tumors; dominant mutation; reduced nucleotidyltransferase activity [UniProt] No UniProt
CA3888961
rs78578389
305 S>R No ClinGen
ExAC
gnomAD
CA364707762
rs1301606288
308 V>A No ClinGen
TOPMed
rs1186282832
CA364707748
311 L>I No ClinGen
TOPMed
gnomAD
rs748096559
CA3888960
311 L>P No ClinGen
ExAC
TOPMed
gnomAD
rs776612878
CA3888959
313 S>G No ClinGen
ExAC
gnomAD
rs768480244
CA3888958
314 E>Q No ClinGen
ExAC
gnomAD
rs1463209696
CA364707721
315 K>E No ClinGen
gnomAD
TCGA novel 315 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs984054493
CA140930961
316 I>M No ClinGen
TOPMed
rs1398456420
CA364707710
316 I>T No ClinGen
gnomAD
rs1170257317
CA364707704
317 S>C No ClinGen
gnomAD
rs1465882305
CA364707702
318 V>M No ClinGen
gnomAD
CA3888956
rs779777358
319 D>A No ClinGen
ExAC
TOPMed
gnomAD
CA140930956
rs368392294
319 D>N No ClinGen
ESP
TOPMed
gnomAD
rs757485722
CA3888955
320 I>M No ClinGen
ExAC
gnomAD
rs749520405
CA3888954
321 T>N No ClinGen
ExAC
gnomAD
rs1192464729
CA364707645
327 K>E No ClinGen
TOPMed
rs909191382
CA140930949
327 K>T No ClinGen
Ensembl
TCGA novel 328 S>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1244665826
CA364707637
328 S>N No ClinGen
TOPMed
rs142038538
CA3888950
329 S>N No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs142038538
CA3888951
329 S>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1562293160
CA364707623
330 W>* No ClinGen
Ensembl
rs375604720
CA3888947
336 E>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs781222574
CA140930943
336 E>K No ClinGen
Ensembl
CA3888945
rs750077245
339 R>C No ClinGen
ExAC
TOPMed
gnomAD
rs190867294
CA3888944
COSM1081549
339 R>H Variant assessed as Somatic; 0.0 impact. endometrium urinary_tract [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
1000Genomes
ExAC
NCI-TCGA
TOPMed
gnomAD
rs190867294
CA364707563
339 R>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs372107956
CA364707562
340 I>F No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA3888943
rs372107956
340 I>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA140930892
rs965574214
340 I>S No ClinGen
TOPMed
CA3888942
rs372107956
340 I>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA364707529
rs1279343949
344 L>P No ClinGen
TOPMed
CA364707517
rs1443125731
346 A>E No ClinGen
TOPMed
gnomAD
rs143905398
CA3888941
347 K>E No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs749518819
CA3888935
353 R>* No ClinGen
ExAC
gnomAD
rs772235312
CA3888934
353 R>Q No ClinGen
ExAC
TOPMed
gnomAD
rs1425856937
CA364707463
355 K>R No ClinGen
gnomAD
CA3888933
rs186480105
356 P>L No ClinGen
1000Genomes
ExAC
gnomAD
rs1237057806
CA364707424
361 P>A No ClinGen
gnomAD
rs781362319
CA3888931
362 K>R No ClinGen
ExAC
gnomAD
rs982007004
CA140930847
363 H>D No ClinGen
Ensembl
CA364707404
rs1287076884
364 A>T No ClinGen
TOPMed
CA140930838
rs764731227
367 G>E No ClinGen
Ensembl
CA140930831
rs748195437
368 N>S No ClinGen
gnomAD
rs1208539248
CA364707355
371 Q>* No ClinGen
gnomAD
CA140922830
rs200205008
375 W>* No ClinGen
TOPMed
gnomAD
COSM196016
CA3888917
rs531954415
376 R>Q Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
CA3888918
rs149902826
376 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1582649217
CA364705215
381 H>P No ClinGen
Ensembl
CA3888912
rs73754628
382 I>M No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA3888913
rs781491185
382 I>V No ClinGen
ExAC
gnomAD
rs750825685
CA3888907
383 E>D No ClinGen
ExAC
TOPMed
gnomAD
rs370272118
CA3888909
383 E>K Variant assessed as Somatic; 4.624e-05 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA3888905
rs756941004
386 I>T No ClinGen
ExAC
gnomAD
CA364705162
rs753473978
389 N>H No ClinGen
ExAC
TOPMed
gnomAD
rs763640060
CA3888903
389 N>S No ClinGen
ExAC
TOPMed
gnomAD
rs753473978
CA3888904
389 N>Y No ClinGen
ExAC
TOPMed
gnomAD
CA3888902
rs755586918
390 H>R No ClinGen
ExAC
TOPMed
gnomAD
rs970823535
CA140922684
391 G>E No ClinGen
TOPMed
gnomAD
rs146116825
CA3888900
393 S>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs376147946
CA3888899
395 T>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1027932064
CA140922616
396 C>* No ClinGen
TOPMed
gnomAD
CA3888897
rs766081918
397 C>R No ClinGen
ExAC
gnomAD
CA3888896
rs762186167
399 N>K No ClinGen
ExAC
gnomAD
rs138458631
CA3888895
400 K>E No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs138458631
CA140922614
400 K>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1478641579
CA364705070
401 E>G No ClinGen
TOPMed
CA3888891
rs747116940
402 E>G No ClinGen
ExAC
gnomAD
rs1054075213
CA140922586
404 C>F No ClinGen
Ensembl
CA364705027
rs1430850836
404 C>S No ClinGen
gnomAD
CA3888869
rs746434360
407 K>E No ClinGen
ExAC
TOPMed
gnomAD
rs774687084
CA3888868
408 D>H No ClinGen
ExAC
gnomAD
rs774687084
CA364704257
408 D>Y No ClinGen
ExAC
gnomAD
rs771383709
CA3888867
409 C>Y No ClinGen
ExAC
gnomAD
CA364704197
rs1306517577
416 L>F No ClinGen
gnomAD
CA364704199
rs1306517577
416 L>I No ClinGen
gnomAD
CA3888865
rs536055666
420 L>Q No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA3888864
rs114473784
422 E>K No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1421515911
CA364704151
423 R>G No ClinGen
TOPMed
rs1166539932
CA364704130
425 K>N No ClinGen
TOPMed
CA140919620
rs919029936
426 D>H No ClinGen
TOPMed
CA364704128
rs919029936
426 D>N No ClinGen
TOPMed
CA364704107
rs1330494068
428 K>N No ClinGen
gnomAD
rs1393435454
CA364704098
429 H>Q No ClinGen
TOPMed
gnomAD
CA364704087
rs1324457133
431 D>E No ClinGen
gnomAD
rs774342634
CA3888862
431 D>N No ClinGen
ExAC
gnomAD
rs774342634
CA140919615
431 D>Y No ClinGen
ExAC
gnomAD
VAR_085525 432 K>T found in patients with uterine endometrioid carcinoma, reduced nucleotidyltransferase activity [UniProt] No UniProt
CA364704078
rs1312755765
433 F>I No ClinGen
TOPMed
gnomAD
COSM451777
rs141390590
CA3888861
433 F>L breast [Cosmic] No ClinGen
cosmic curated
ESP
ExAC
TOPMed
gnomAD
CA3888860
rs377097470
436 Y>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA364704048
rs148298509
437 H>L No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA3888859
rs148298509
437 H>R No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1255242854
CA364704024
441 A>S No ClinGen
gnomAD
CA3888857
rs372631572
442 F>C No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA364704018
rs1486650584
442 F>L No ClinGen
gnomAD
CA140919566
rs1056714207
444 H>N No ClinGen
Ensembl
CA3888854
rs570427952
445 V>I No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA3888855
rs570427952
445 V>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA364703973
rs1562289640
448 Q>H No ClinGen
Ensembl
rs976907040
CA140919537
450 P>R No ClinGen
TOPMed
gnomAD
rs924697459
CA140919544
450 P>S No ClinGen
TOPMed
gnomAD
CA3888851
rs200818241
452 D>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA3888850
rs759563628
454 Q>* No ClinGen
ExAC
gnomAD
CA3888849
rs774436118
456 D>E No ClinGen
ExAC
gnomAD
rs1031745357
CA140919520
457 R>C No ClinGen
TOPMed
gnomAD
CA140919518
rs968744350
457 R>L No ClinGen
Ensembl
CA140919517
rs975717163
458 K>* No ClinGen
TOPMed
gnomAD
CA364703908
rs975717163
458 K>E No ClinGen
TOPMed
gnomAD
CA3888846
rs746885325
462 L>V No ClinGen
ExAC
TOPMed
gnomAD
rs1582647332
CA364703868
464 F>L No ClinGen
Ensembl
CA3888844
rs747885400
464 F>L No ClinGen
ExAC
gnomAD
rs1192897199
CA364703843
467 C>F No ClinGen
gnomAD
CA3888842
rs551846495
467 C>G No ClinGen
1000Genomes
ExAC
gnomAD
rs1192897199
CA364703844
467 C>Y No ClinGen
gnomAD
CA364703840
rs779657218
468 V>L No ClinGen
ExAC
TOPMed
gnomAD
CA3888840
rs779657218
468 V>M No ClinGen
ExAC
TOPMed
gnomAD
rs1467655080
CA364703780
472 L>H No ClinGen
TOPMed
CA3888835
rs756968288
474 C>* No ClinGen
ExAC
TOPMed
gnomAD
rs778913574
CA3888836
474 C>Y No ClinGen
ExAC
TOPMed
gnomAD
rs1276816495
CA364703697
477 T>I No ClinGen
gnomAD
rs1327079970
CA364703685
478 E>G No ClinGen
gnomAD
TCGA novel 479 K>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA364703608
rs1234011055
483 Y>D No ClinGen
TOPMed
rs138984002
CA3888834
483 Y>F No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA140919392
rs895735379
485 I>F No ClinGen
TOPMed
gnomAD
CA3888833
rs767651417
486 P>A No ClinGen
ExAC
gnomAD
CA364703555
rs1211647911
486 P>L Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA364703500
rs1462781567
489 N>S No ClinGen
gnomAD
CA364703505
rs1165928919
489 N>Y No ClinGen
gnomAD
rs766441481
CA3888830
493 S>G No ClinGen
ExAC
gnomAD
CA364703434
rs1475721740
493 S>I No ClinGen
gnomAD
rs763507557
CA3888829
495 L>I No ClinGen
ExAC
gnomAD
rs773685659
CA3888828
497 D>Y No ClinGen
ExAC
gnomAD
COSM3430862
rs1206488804
CA364703368
499 R>I large_intestine Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
CA364703351
rs311678
CA364703350
501 K>N No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1449920881
CA364703340
503 F>L No ClinGen
TOPMed
rs1215213174
CA364703314
505 T>A No ClinGen
TOPMed
gnomAD
rs974303140
CA140919330
507 Q>* No ClinGen
Ensembl
CA827927299
rs1434791944
509 E>D No ClinGen
TOPMed
CA140919328
rs777006094
509 E>D No ClinGen
ExAC
gnomAD
rs1429018382
CA364703218
511 E>A No ClinGen
gnomAD
rs768207867
CA3888824
512 R>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs529824524
CA3888822
514 N>S No ClinGen
1000Genomes
ExAC
gnomAD

No associated diseases with Q8N884

2 regional properties for Q8N884

Type Name Position InterPro Accession
domain Mab-21-like, nucleotidyltransferase domain 214 - 389 IPR046903
domain Mab-21-like, HhH/H2TH-like domain 405 - 509 IPR046906

Functions

Description
EC Number 2.7.7.86 Nucleotidyltransferases
Subcellular Localization
  • Nucleus
  • Chromosome
  • Cell membrane ; Peripheral membrane protein
  • Cytoplasm, cytosol
  • Mainly localizes in the nucleus, and at low level in the cytosol (PubMed:31544964, PubMed:31808743)
  • On chromosomes, enriched on centromeric satellite and LINE DNA repeat elements (PubMed:30811988)
  • Exported from the nucleus to the cytosol in a XPO1/CRM1 via the nuclear export signal in response to DNA stimulation (PubMed:33406424)
  • Outside the nucleus, localizes at the cell membrane as a peripheral membrane protein in resting conditions: association to the cell membrane is mediated via binding to phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) (PubMed:30827685)
  • Localization at the cell membrane is required to limit the recognition of self-DNA (PubMed:30827685)
  • Following detection of double-stranded DNA (dsDNA), released from the cell membrane into the cytosol in order to signal (PubMed:30827685)
  • Upon transfection with dsDNA forms punctate structures that co-localize with DNA and Beclin-1 (BECN1) (PubMed:26048138)
  • Phosphorylation at Tyr-215 promotes cytosolic retention (PubMed:30356214)
  • In response to translation stress, translocates to the cytosol and associates with collided ribosomes (PubMed:34111399)
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

5 GO annotations of cellular component

Name Definition
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
site of double-strand break A region of a chromosome at which a DNA double-strand break has occurred. DNA damage signaling and repair proteins accumulate at the lesion to respond to the damage and repair the DNA to form a continuous DNA helix.

12 GO annotations of molecular function

Name Definition
2',3'-cyclic GMP-AMP synthase activity Catalysis of the reaction: ATP + GTP = 2 diphosphate + cyclic G-P(2'-5')A-P(3'-5') (cyclic 2',3' GAMP).
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
chromatin binding Binding to chromatin, the network of fibers of DNA, protein, and sometimes RNA, that make up the chromosomes of the eukaryotic nucleus during interphase.
DNA binding Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
double-stranded DNA binding Binding to double-stranded DNA.
GTP binding Binding to GTP, guanosine triphosphate.
metal ion binding Binding to a metal ion.
molecular condensate scaffold activity Binding and bringing together two or more macromolecules in contact, permitting those molecules to organize as a molecular condensate.
nucleosome binding Binding to a nucleosome, a complex comprised of DNA wound around a multisubunit core and associated proteins, which forms the primary packing unit of DNA into higher order structures.
phosphatidylinositol-4,5-bisphosphate binding Binding to phosphatidylinositol-4,5-bisphosphate, a derivative of phosphatidylinositol in which the inositol ring is phosphorylated at the 4' and 5' positions.
poly-ADP-D-ribose modification-dependent protein binding Binding to a protein upon poly-ADP-ribosylation of the target protein.
protein homodimerization activity Binding to an identical protein to form a homodimer.

16 GO annotations of biological process

Name Definition
activation of innate immune response Any process that initiates an innate immune response. Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens. Examples of this process include activation of the hypersensitive response of Arabidopsis thaliana and activation of any NOD or TLR signaling pathway in vertebrate species.
cAMP-mediated signaling Any intracellular signal transduction in which the signal is passed on within the cell via cyclic AMP (cAMP). Includes production of cAMP, and downstream effectors that further transmit the signal within the cell.
cellular response to DNA damage stimulus Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to its DNA from environmental insults or errors during metabolism.
cellular response to exogenous dsRNA Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an exogenous double-stranded RNA stimulus.
cGMP-mediated signaling Any intracellular signal transduction in which the signal is passed on within the cell via cyclic GMP (cGMP). Includes production of cGMP, and downstream effectors that further transmit the signal within the cell.
defense response to virus Reactions triggered in response to the presence of a virus that act to protect the cell or organism.
determination of adult lifespan The pathways that regulate the duration of the adult phase of the life-cycle of an animal.
DNA repair The process of restoring DNA after damage. Genomes are subject to damage by chemical and physical agents in the environment (e.g. UV and ionizing radiations, chemical mutagens, fungal and bacterial toxins, etc.) and by free radicals or alkylating agents endogenously generated in metabolism. DNA is also damaged because of errors during its replication. A variety of different DNA repair pathways have been reported that include direct reversal, base excision repair, nucleotide excision repair, photoreactivation, bypass, double-strand break repair pathway, and mismatch repair pathway.
innate immune response Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.
negative regulation of double-strand break repair via homologous recombination Any process that stops, prevents, or reduces the frequency, rate or extent of double-strand break repair via homologous recombination.
paracrine signaling The transfer of information from one cell to another, where the signal travels from the signal-producing cell to the receiving cell by passive diffusion or bulk flow in intercellular fluid. The signaling cell and the receiving cell are usually in the vicinity of each other.
positive regulation of cellular senescence Any process that activates or increases the frequency, rate or extent of cellular senescence.
positive regulation of defense response to virus by host Any host process that results in the promotion of antiviral immune response mechanisms, thereby limiting viral replication.
positive regulation of type I interferon production Any process that activates or increases the frequency, rate, or extent of type I interferon production. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families.
regulation of immunoglobulin production Any process that modulates the frequency, rate, or extent of immunoglobulin production.
regulation of T cell activation Any process that modulates the frequency, rate or extent of T cell activation.

4 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
E1BGN7 CGAS Cyclic GMP-AMP synthase Bos taurus (Bovine) PR
Q8C525 Mb21d2 Nucleotidyltransferase MB21D2 Mus musculus (Mouse) PR
Q8C6L5 Cgas Cyclic GMP-AMP synthase Mus musculus (Mouse) PR
I3LM39 CGAS Cyclic GMP-AMP synthase Sus scrofa (Pig) PR
10 20 30 40 50 60
MQPWHGKAMQ RASEAGATAP KASARNARGA PMDPTESPAA PEAALPKAGK FGPARKSGSR
70 80 90 100 110 120
QKKSAPDTQE RPPVRATGAR AKKAPQRAQD TQPSDATSAP GAEGLEPPAA REPALSRAGS
130 140 150 160 170 180
CRQRGARCST KPRPPPGPWD VPSPGLPVSA PILVRRDAAP GASKLRAVLE KLKLSRDDIS
190 200 210 220 230 240
TAAGMVKGVV DHLLLRLKCD SAFRGVGLLN TGSYYEHVKI SAPNEFDVMF KLEVPRIQLE
250 260 270 280 290 300
EYSNTRAYYF VKFKRNPKEN PLSQFLEGEI LSASKMLSKF RKIIKEEIND IKDTDVIMKR
310 320 330 340 350 360
KRGGSPAVTL LISEKISVDI TLALESKSSW PASTQEGLRI QNWLSAKVRK QLRLKPFYLV
370 380 390 400 410 420
PKHAKEGNGF QEETWRLSFS HIEKEILNNH GKSKTCCENK EEKCCRKDCL KLMKYLLEQL
430 440 450 460 470 480
KERFKDKKHL DKFSSYHVKT AFFHVCTQNP QDSQWDRKDL GLCFDNCVTY FLQCLRTEKL
490 500 510 520
ENYFIPEFNL FSSNLIDKRS KEFLTKQIEY ERNNEFPVFD EF